Updated Genomic Medicine for Lung Cancer: The Clinical Usefulness and Future Issues Associated with Analytical Technologies for Cell-free DNA in Peripheral Blood-Reference-Cited by-同舟云学术

Updated Genomic Medicine for Lung Cancer: The Clinical Usefulness and Future Issues Associated with Analytical Technologies for Cell-free DNA in Peripheral Blood

Published:2020-04-20 Issue:2 Volume:60 Page:90-98
ISSN:0386-9628
Container-title:Haigan
language:en
Short-container-title:JJLC

Author:

Goto Yasushi¹

Affiliation:

1. Department of Thoracic Oncology, National Cancer Center Hospital

Publisher

Japan Lung Cancer Society

Subject

Pulmonary and Respiratory Medicine,Oncology

Link

https://www.jstage.jst.go.jp/article/haigan/60/2/60_90/_pdf

Reference26 articles.

1. 2. Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H, et al. North-East Japan Study Group. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med. 2010; 362: 2380-2388.

2. 3. Cardarella S, Johnson BE. The impact of genomic changes on treatment of lung cancer. Am J Respir Crit Care Med. 2013; 188: 770-775.

3. 5. Akamatsu H, Ninomiya K, Kenmotsu H, Morise M, Daga H, Goto Y, et al. The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV. Int J Clin Oncol. 2019; 24: 731-770.

4. 6. Jamal-Hanjani M, Wilson GA, McGranahan N, Birkbak NJ, Watkins TBK, Veeriah S, et al. Tracking the Evolution of Non-Small-Cell Lung Cancer. N Engl J Med. 2017; 376: 2109-2121.

5. 7. Siravegna G, Marsoni S, Siena S, Bardelli A. Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol. 2017; 14: 531-548.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive Biomarker Testing for Lung Cancer: Past and Future Perspectives;Haigan;2022-02-20